ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

10,579Medicare Part D Prescriptions Filled, Including Refills

Rank: 27 out of 298

$514K Total Retail Price of All Prescriptions

Rank: 26 out of 298

485 Patients Receiving at Least One Drug in Part D
83%Patients 65 Years and Older
42% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in South Dakota
Lower avg

Schedule Two
Controlled Substances

5% of this provider’s 485 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

11% of this provider’s 485 patients filled at least one prescription for a schedule three drug, compared to an average of 10%.

Risky Drugs to Seniors

1% of this provider’s 8,451 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

20% of this provider’s prescriptions were for brand-name drugs, compared to an average of 22%.

Prescription Price

$49 was the average price of a prescription from this provider, compared to $50 among peers.

Prescriptions per Patient

22 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in South Dakota
LISINOPRIL 503 398 1 4
LEVOTHYROXINE SODIUM 482 394 2 1
SIMVASTATIN 366 324 3 2
OMEPRAZOLE 302 222 4 3
FUROSEMIDE 274 241 5 5
CITALOPRAM HBR 272 209 6 17
AMLODIPINE BESYLATE 245 229 7 6
ATENOLOL 237 216 8 16
METFORMIN HCL 215 146 9 10
WARFARIN SODIUM 210 193 10 7
ALENDRONATE SODIUM 204 160 11 21
HYDROCODONE-ACETAMINOPHEN 203 188 S3 12 8
CRESTOR 166 130 13 26
POTASSIUM CHLORIDE 166 150 13 11
TORSEMIDE 159 148 15 110
GLIPIZIDE 153 127 16 69
LOSARTAN POTASSIUM 152 128 17 18
PREDNISONE 138 122 18 33
GABAPENTIN 136 107 19 20
METOPROLOL TARTRATE 132 91 20 9
SPIRONOLACTONE 130 127 21 34
SERTRALINE HCL 126 87 22 19
METOPROLOL SUCCINATE 120 108 23 12
DICLOFENAC SODIUM 114 69 24 138
TRAZODONE HCL 113 87 25 39
OXYBUTYNIN CHLORIDE 109 71 26 81
TERAZOSIN HCL 105 85 27 72
CLOPIDOGREL 93 68 28 36
FENTANYL 91 75 S2 29 32
ATORVASTATIN CALCIUM 91 58 29 14
TRAMADOL HCL 88 82 31 15
DIGOXIN 83 80 32 27
CIPROFLOXACIN HCL 83 73 32 56
DONEPEZIL HCL 80 80 34 22
CARBIDOPA-LEVODOPA 80 80 34 49
RISPERIDONE 78 73 36 54
TAMSULOSIN HCL 75 66 37 24
HYDROCHLOROTHIAZIDE 67 58 38 13
PLAVIX 67 52 38 70
FINASTERIDE 67 64 38 66
LANTUS 67 22 38 53
AZITHROMYCIN 64 50 42 63
CARVEDILOL 62 50 43 23
CEFDINIR 61 48 44 174
SPIRIVA 58 45 45 55
DIVALPROEX SODIUM 58 48 45 91
MELOXICAM 56 45 47 41
ZOLPIDEM TARTRATE 52 38 48 25
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Nov. 25, 2011.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.